[Cost-effectiveness of samarium-153-EDTMP for the treatment of pain due to multiple bone metastases in hormone-refractory prostate cancer versus conventional pain therapy, in Portugal].
作者:
主题词
镇痛药, 非麻醉(Analgesics, Non-Narcotic);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);骨肿瘤(Bone Neoplasms);费用效益分析(Cost-Benefit Analysis);人类(Humans);男(雄)性(Male);有机金属化合物(Organometallic Compounds);有机磷化合物(Organophosphorus Compounds);疼痛(Pain);葡萄牙(Portugal);前列腺肿瘤(Prostatic Neoplasms);治疗失败(Treatment Failure)
PMID
17376329
发布时间
2016-11-24
- 浏览0
Acta medica portuguesa
421-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文